U.S. Blood-Based Biomarker Market for Parkinson’s Disease...

σε πρόσθεσε στο άλλο

2025-07-17 06:52:16 -

U.S. Blood-Based Biomarker Market for Parkinson’s Disease Projected to Reach USD 1,156.34 Million by 2034, Growing at a CAGR of 19.6%

Market Overview The U.S. blood-based biomarker for Parkinson’s disease market was valued at USD 194.41 million in 2024 and is projected to grow significantly to reach USD 1,156.34 million by 2034, registering a compound annual growth rate (CAGR) of 19.6% during the forecast period from 2025 to 2034. This exponential growth reflects the increasing demand...

0 Σχόλια 0 Μοιράστηκε 14 Views